Century Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Century Capital Management's CRL Position: Q2 2017 in Review
Century Capital Management reduced its Charles River Laboratories (CRL) stake by 16% in Q2 2017, selling an estimated $926K and leaving 54,577 shares worth $5.52M. The position accounts for 0.95% of the portfolio, ranked #30.
Century Capital Management first reported a position in CRL in Q2 2013 and has held it in 10 quarters since. The position peaked at $12.5M in Q2 2016. 302 funds tracked by Wall St. Rank hold CRL as of Q2 2017.
- Century Capital Management held 54,577 shares of Charles River Laboratories worth $5.52M as of Q2 2017.
- Century Capital Management sold 10,061 Charles River Laboratories shares in Q2 2017, an estimated $926K.
- Charles River Laboratories made up 0.95% of Century Capital Management's portfolio in Q2 2017, its #30 holding.
- Century Capital Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 10 quarters since.
- Century Capital Management's Charles River Laboratories position peaked at $12.5M in Q2 2016.
- 302 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2017.
Based on Century Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.